Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
G-CSF vs Placebo in Recurrent Miscarriage
NCT00772122Phase 4Completed
- Sponsor
- Università degli Studi di Firenze
- Start
- Jan 2000
- Primary completion
- Jan 2007
- Modality
- Cytokines & Interferons
- Countries
- 1
01
Overview
A Phase 4 trial of filgrastim in recurrent miscarriage (RPL), sponsored by Università degli Studi di Firenze. Started Jan 2000; status: completed.
02
Drugs
filgrastim
03
Conditions
recurrent miscarriage (RPL)
Beyond the preview
Go deeper on NCT00772122.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00772122.